HC Wainwright & Co. Reiterates Buy on Alto Neuroscience, Maintains $50 Price Target

Alto Neuroscience, Inc.

Alto Neuroscience, Inc.

ANRO

0.00

HC Wainwright & Co. analyst Patrick R. Trucchio reiterates Alto Neuroscience (NYSE: ANRO) with a Buy and maintains $50 price target.